• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全科医生与泌尿科医生在良性前列腺增生管理中的共同照护:临床医生态度调查

Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians.

作者信息

Kirby R S, Chisholm G, Chapple C, Hudd C, Swallow M, Shore D

机构信息

Western General Infirmary, Edinburgh, Scotland.

出版信息

J R Soc Med. 1995 May;88(5):284P-288P.

PMID:7543576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1295206/
Abstract

Recent community-based population surveys have revealed a much greater prevalence of benign prostatic hyperplasia than previously suspected. From these data it has been projected that there may be more than 2 million men in the UK whose quality of life is to some extent impaired by this disorder. Since there are only 330 fully trained urologists in this country it will not be feasible for every individual presenting with prostatism to be assessed by a specialist. In an attempt to provide a more rational basis from which family practitioners can decide whether or not to refer a patient for a specialist opinion a 'shared care' flow diagram was developed and assumptions contained within field tested by means of a postal questionnaire which was sent to 2020 urologists, family practitioners and other interested clinicians. There was general agreement with most of the precepts set out in the flow diagram, the main exception was a rejection of the suggestion that every patient with prostatism should have a prostate-specific antigen level determined before referral. We conclude that there seems a consensus among respondents that a shared care approach to the management of BPH may both improve the standard of care provided in this area by family practitioners and allow hard pressed urologists to focus greater attention on those patients whose conditions require surgical expertise to resolve.

摘要

最近基于社区的人口调查显示,良性前列腺增生的患病率比之前预想的要高得多。根据这些数据推测,在英国可能有超过200万男性的生活质量在某种程度上受到这种疾病的损害。由于该国仅有330名训练有素的泌尿科医生,因此让每位出现前列腺增生症状的患者都由专科医生进行评估是不可行的。为了提供一个更合理的依据,以便家庭医生决定是否将患者转诊以获取专科意见,制定了一个“共享护理”流程图,并通过向2020名泌尿科医生、家庭医生和其他感兴趣的临床医生发送邮政问卷的方式,对该流程图中的假设进行了实地测试。对于流程图中列出的大多数准则,大家普遍表示认同,主要的例外是拒绝接受以下建议:每位前列腺增生患者在转诊前都应检测前列腺特异性抗原水平。我们得出的结论是,受访者之间似乎达成了共识,即采用共享护理方法来管理良性前列腺增生,既可以提高家庭医生在该领域提供的护理标准,又能让忙碌的泌尿科医生将更多注意力集中在那些需要手术专业知识来解决病情的患者身上。

相似文献

1
Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians.全科医生与泌尿科医生在良性前列腺增生管理中的共同照护:临床医生态度调查
J R Soc Med. 1995 May;88(5):284P-288P.
2
Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.泌尿科医生和初级保健医生对良性前列腺增生的评估和管理:来自观察性 BPH 登记处的实践模式。
J Urol. 2011 Sep;186(3):971-6. doi: 10.1016/j.juro.2011.04.081. Epub 2011 Jul 24.
3
[Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
Ned Tijdschr Geneeskd. 1998 Nov 21;142(47):2563-8.
4
[General practitioners' approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany].[全科医生对50岁以上男性排尿障碍的处理方法。对布列塔尼250名医生的调查]
Prog Urol. 1996 Feb;6(1):52-9.
5
Management of symptomatic BPH in the UK: who is treated and how?英国有症状良性前列腺增生症的管理:哪些人接受治疗以及如何治疗?
Eur Urol. 1999;36 Suppl 3:33-9. doi: 10.1159/000052347.
6
[Consensus document on the management and follow-up of the male with lower urinary tract symptoms secondary to benign prostate hyperplasia].[良性前列腺增生继发下尿路症状男性的管理与随访共识文件]
Semergen. 2016 Nov-Dec;42(8):547-556. doi: 10.1016/j.semerg.2016.09.008. Epub 2016 Oct 27.
7
[Benign prostatic hyperplasia. Shared care between urologists and general practitioners].
Tidsskr Nor Laegeforen. 1997 Jan 30;117(3):389-93.
8
Management of symptomatic BPH in Italy: who is treated and how?意大利症状性良性前列腺增生症的管理:哪些人接受治疗以及如何治疗?
Eur Urol. 1999;36 Suppl 3:28-32. doi: 10.1159/000052346.
9
Shared care and the management of lower urinary tract symptoms.共享护理与下尿路症状的管理
BJU Int. 2004 Dec;94(9):1287-90. doi: 10.1111/j.1464-410X.2004.05159.x.
10
Management of symptomatic BPH in France: who is treated and how?法国有症状良性前列腺增生症的管理:哪些人接受治疗以及如何治疗?
Eur Urol. 1999;36 Suppl 3:14-20. doi: 10.1159/000052344.

引用本文的文献

1
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.全球范围内前列腺特异性抗原检测政策差异很大,似乎不符合指南:系统评价。
BMC Fam Pract. 2012 Oct 11;13:100. doi: 10.1186/1471-2296-13-100.
2
Diagnosis and management of benign prostatic hyperplasia in primary care.基层医疗中良性前列腺增生的诊断与管理
Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S92-S100. doi: 10.5489/cuaj.1116.

本文引用的文献

1
Long-term urodynamic effects of finasteride in benign prostatic hyperplasia: a pilot study.非那雄胺对良性前列腺增生症的长期尿动力学影响:一项初步研究。
Eur Urol. 1993;24(1):20-6. doi: 10.1159/000474256.
2
Impact of benign prostatic hyperplasia on general well-being of men.
Prostate. 1993;23(1):1-7. doi: 10.1002/pros.2990230102.
3
The prevalence of prostatism: a population-based survey of urinary symptoms.
J Urol. 1993 Jul;150(1):85-9. doi: 10.1016/s0022-5347(17)35405-8.
4
Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study.
Scand J Urol Nephrol. 1993;27(1):39-44. doi: 10.3109/00365599309180412.
5
Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.局限于器官内、不可触及的移行带大前列腺癌:与前列腺特异性抗原转移水平的关联
J Urol. 1993 Mar;149(3):510-5. doi: 10.1016/s0022-5347(17)36131-1.
6
Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group.特拉唑嗪治疗良性前列腺增生。特拉唑嗪良性前列腺增生研究组。
Arch Fam Med. 1993 Sep;2(9):929-35. doi: 10.1001/archfami.2.9.929.
7
Prostatic surgery for benign prostatic hyperplasia: meeting the expanding demand.良性前列腺增生的前列腺手术:满足不断增长的需求。
Br J Urol. 1993 Nov;72(5 Pt 2):761-5. doi: 10.1111/j.1464-410x.1993.tb16263.x.
8
The development of human benign prostatic hyperplasia with age.人类良性前列腺增生随年龄的发展。
J Urol. 1984 Sep;132(3):474-9. doi: 10.1016/s0022-5347(17)49698-4.
9
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.前列腺特异性抗原作为前列腺腺癌的血清标志物。
N Engl J Med. 1987 Oct 8;317(15):909-16. doi: 10.1056/NEJM198710083171501.
10
Rectal examination in general practice.全科医疗中的直肠检查。
BMJ. 1990 Sep 8;301(6750):478-80. doi: 10.1136/bmj.301.6750.478.